Bispecific CD37-Siglec6 CAR‑T cells exhibit enhanced anti‑leukemic activity and reduced exhaustion in acute myeloid leukemia xenograft models.

J Transl Med · 2026 · PMC13255234 · PMID 42035126

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

TCGA data showed that high CD37 expression was significantly associated with poor prognosis ( P < 0.05), whereas high Siglec6 expression showed a trend toward unfavorable prognosis (Fig. 2 C-D).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.